PRIMACYT – Cryopreserved Mouse Hepatocytes

We develop and provide cell culture systems for the prediction of toxic and long-term effects of agents on the human body. Worldwide support of biomedical and cell biology research as well as industrial communities.We accompany projects to fully understand the metabolism, toxicity and functional effects of the liver system.

Our Strengths

PRIMACYT is one of the pioneers in the development of advanced in vitro model systems. We are a leading company in the field of research of human and animal hepatocytes.
In 2008, we have received the Research Prize of the German Ministry of Nutrition, Agriculture and Consumer Protection for the “Development and validation of a serum-free, standardized and re-usable human hepatocyte culture system for the analysis of food, drugs and chemicals”.
PRIMACYT is approved by the European Commission as an EU Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM) since 2013 and serves as a member of the laboratory network responsible for the method validation.
Main products, liver-derived and skin-derived products, are cryopreserved at the first passage stage, and the product information below clearly states the viability, recovery rate, suitable plates for culture, and test results for 3D culture.

Mouse (Mus musculus) Hepatocytes Order Information

Overview

The liver fulfills many vital processes in mammals. It is the central organ of energy metabolism, responsible for the maintenance of the blood sugar level and the synthesis of plasma proteins under physiological and pathophysiological conditions. Cryopreserved primary liver cells are perfectly suited for in vitro metabolism and toxicity / detoxification studies prior to preclinical or clinical tests.

Parenchymal hepatocytes are the most prominent cells within the liver. Hepatocytes eliminate toxic substances from the blood. As part of this biotransformation process, influx and efflux transporter proteins, together with phase I reactions (cytochrome P450 proteins), and phase II reactions, primarily glucuronidation and sulfation, play a central role.

NPCs play a pivotal role during inflammatory response and fibrosis, interacting with hepatocytes and thereby complementing the liver-specific functions. Non-parenchymal liver cells, NPCs, include Kupffer cells, endothelial cells, and fat-storing cells, such as Ito cells, hepatic stellate cells).

Mouse hepatocytes are isolated from livers obtained from male or female mice and are cryopreserved directly after isolation. Cryopreserved mouse hepatocytes are used in suspension assays and plated in 2D and 3D cell cultures.

Literature

n drug development, at least two in vivo repeated–dose toxicity studies of a drug candidate have to be performed in two different animal species before human studies can be initiated (https://www.fda.gov/downloads/drug /guidancecomplianceregulatoryinformation/guidances/ucm292340.pdf). In most cases these species are mouse or rat and dog or monkey.

Hepatotoxicity is a major cause for failure in drug development. For interpretation of hepatotoxicity data, it is important to understand potential interspecies differences in mechanisms that lead to drug toxicity. This includes

  • ・drug uptake into the liver,
  • ・biotransformation of the drug (Phase I and Phase II), and
  • ・drug efflux from the liver

Interspecies differences in expression and activities in transport proteins and biotransformation enzymes may result in different intra– and extrahepatic concentrations of the drug.

Quantification of drug transporter protein by LC/MS has revealed significant interspecies differences in the expression of uptake and efflux transporters. On the other hand, in beagle hepatocytes expression of the two most important Organic Anion Transporters Oatp1a2 and Oatp1b4 (equivalent to human OATP1B1 and OATP1B3) was maintained at the same level as in dog liver tissue (Wang et al. 2014).

Wang L, Prasad B, Salphati L, Chu X, Gupta A, Hop C E.C.A., Evers R, and Unadkat J. D.: Interspecies Variability in Expression of Hepatobiliary Transporters across Human, Dog, Monkey, and Rat as Determined by Quantitative Proteomics, Drug Metab.
Dispos., 2015, 43:367–374

Product List

Product Code Lot + CoA Gender Inventory Viability (%) Recovery (Viable cells/vial) plateable on 24well plateable on 96well 3D culture CYP1A1/1A2 induction x-fold
MHCP MH200715 female, Pool of 4 6 in stock 75.9 > 2 Mio. yes no not tested
MHCP MH250226 female, Pool of 2 6 in stock 85.4 > 2 Mio. yes no no
MHCP MH240522 male, pool of 8 28 in stock 86.5 < 2 Mio. yes no no
MHCP MH240226 male 4 in stock 89.4 < 2 Mio. yes no no
MHCP MH231205 male 7 in stock 89.7 > 2 Mio. yes no no
MHCP MH240515-2 male, Pool of 2 5 in stock 78.3 > 2 Mio. yes yes no
MHCP MH240515-1 male, Pool of 6 14 in stock 81.3 > 2 Mio. yes yes no
MHCP MH210603 female, Pool of 2 12 in stock 81.6 > 2 Mio. yes no not tested no
MHCP-aged MH220119 female 1 in stock 61.1 > 2 Mio. yes no not tested 1.4
MHCP-aged MH220815 female 6 in stock 74.0 > 2 Mio. yes no not tested no
MHCP-aged MH220202-1 female 5 in stock 85.8 > 2 Mio. yes yes not tested 1.0
MHCP-I MH210308 female, Pool of 2 3 in stock 86.6 < 2 Mio. yes no not tested 1.8
MHCP-I MH191028 female 3 in stock 76.7 > 2 Mio. yes no not tested 3.4
MHCP-I MH250407 male, pool of 2 11 in stock 87.9 < 2 Mio. yes no no 5.8
MHCP-I MH250319 Pool of 2, female 11 in stock 88.4 > 2 Mio. yes yes no 3.0
MHCP-I MH220927 female 3 in stock 85.2 < 2 Mio. yes yes not tested 5.9
MHCP-I MH240821 male 2 in stock 91.7 > 2 Mio. yes yes no 3.6
MHCP-I MH240910 Pool of 5, male 29 in stock 86.9 > 2 Mio. yes yes no 2.0
MHCP-I MH241119 female, pool of 4 25 in stock 89.2 < 2 Mio. yes not tested no 2.5
MHCP-I MH241112 female, pool of 6 38 in stock 91.1 > 2 Mio. yes no no 5.4
MHCP-I MH240319 male, pool of 7 3 in stock 82.6 > 2 Mio. yes yes not tested 3.8
MHCP-I-aged MH220412 female 3 in stock 83.3 > 2 Mio. yes yes not tested 4.2
MHCP-I-3D MH240618 male 5 in stock 76.3 > 2 Mio. yes yes yes 3.1
MHCP-I-3D MH231113 male 4 in stock 83.5 < 2 Mio. yes no yes 4.7
MHCP-I-3D MH210907 male 6 in stock 89.5 +/- 4.9 > 2 Mio. yes no yes 3.7
BL6-MHCP MH240828 male, pool of 3 18 in stock 88.4 > 2 Mio. yes yes no
BL6-MHCP MH240826 male, pool of 3 8 in stock 89.5 > 2 Mio. yes yes no
BL6-MHCP MH240807 male, pool of 8 20 in stock 81.6 > 2 Mio. yes yes no
BL6-MHCP-I MH240111-3 male 1 in stock 85.5 > 2 Mio. yes yes no 2.3
BL6-MHCP-I MH240111-2 male 2 in stock 85.4 > 2 Mio. yes yes no 3
BL6-MHCP-I-3D MH240111-1 male 5 in stock 86.3 > 2 Mio. yes no yes 6.2


MHCP-I-3D: Mouse Hepatocytes Cryopreserved Plateable, Cytochrome P450 inducible, Suitable for 3D culture
MHCP-I: Mouse Hepatocytes Cryopreserved Plateable, Cytochrome P450 inducible
MHCP: Mouse Hepatocytes Cryopreserved Plateable
MHCS: Mouse Hepatocytes for use in suspension studies

Back

Please contact us for any inquiries, questions, or information requests.
Tokyo Future Style, Inc.
info@tokyofuturestyle.com
TEL:029-851-9222 FAX:029-851-9220

一覧へ戻る場合はこちらをクリックして下さい。